IVBIAEvaluation of Bariatric Surgery Impact on Morbidly Obese Patients: Pre and Post-Surgery Comparison
This study aims to observe and compare the prevalence of anal incontinence in morbidly obese patients before and after bariatric surgery, using the PFDI-20 score as a measure of severity.
Data Collection
Collected from today forward - ProspectiveBehavior+12
+ Mental Disorders
+ Behavioral Symptoms
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 22, 2020
Actual date on which the first participant was enrolled.This study focuses on obese individuals who are considering bariatric surgery. The goal is to understand the impact of this surgery on their health, with a special focus on a condition called anal incontinence. The study follows current French national recommendations and spans about a year. It includes people with various health conditions related to obesity, such as diabetes, sleep apnea, hypertension, and depression. The study collects information from medical records and self-questionnaires. These questionnaires are filled out by the participants around 6 weeks before the surgery and again during a follow-up visit 6 months after the surgery. The main outcome of interest is the change in the prevalence of anal incontinence before and after the surgery. This is measured using a score called the PFDI-20, which ranges from zero (no incontinence) to 12 (severe incontinence).
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.300 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage)
Nancy, FranceOpen CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage) in Google Maps